Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G. M. Bores"'
Publikováno v:
Brain Research Bulletin. 46:423-427
Abeta1-40 (20 microM) has been reported to selectively inhibit Na+/K+-ATPase activity in rat primary hippocampal cultures after 2-6 days of exposure. We expanded these studies to include Abeta's effects on Na+/K+-ATPase activity in rat primary cortic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2998803b59cb1bbf29c5c3c4493bea
https://doi.org/10.1016/s0361-9230(97)00382-1
https://doi.org/10.1016/s0361-9230(97)00382-1
Autor:
Lawrence L. Martin, Douglas K. Rush, J. E. Roehr, J. T. Klein, Francis P. Huger, M. R. Szewczak, R. Corbett, A. Giovanni, Richard C. Effland, R. D. Porsolt, A. T. Woods-Kettelberger, C. P. Smith, D. J. Turk, E. M. DiLeo, G. M. Bores, S. Kongsamut
Publikováno v:
CNS Drug Reviews. 3:1-23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74aa22289c43b54f05aef244161c3e30
https://doi.org/10.1111/j.1527-3458.1997.tb00313.x
https://doi.org/10.1111/j.1527-3458.1997.tb00313.x
Autor:
A. T. Woods-Kettelberger, R. Corbett, S. Kongsamut, J. T. Klein, M. R. Szewczak, G. M. Bores, C. P. Smith, J. E. Roehr
Publikováno v:
Brain Research Bulletin. 41:125-130
The aim of the present paper is to report on the adrenergic and serotonergic effects of besipirdine (HP 749) in vivo and to discuss its potential use in the treatment of obsessive compulsive disorder. Besipirdine inhibited biogenic amine uptake in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7ae06f904de97fbb931843b5e8a8332
https://doi.org/10.1016/0361-9230(96)00163-3
https://doi.org/10.1016/0361-9230(96)00163-3
Autor:
C P, Smith, G M, Bores, W, Petko, M, Li, D E, Selk, D K, Rush, F, Camacho, J T, Winslow, R, Fishkin, D M, Cunningham, K M, Brooks, J, Roehr, H B, Hartman, L, Davis, H M, Vargas
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 280(2)
1-[(3-Fluoro-4-pyridinyl)amino]-3-methyl-1(H)-indol-5-yl methyl carbamate (P10358) is a potent, reversible acetylcholinesterase inhibitor that produces central cholinergic stimulation after oral and parental administration in rats and mice. P10358 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5341035c9e227d7dd84b87a3631a028e
https://pubmed.ncbi.nlm.nih.gov/9023283
https://pubmed.ncbi.nlm.nih.gov/9023283
Autor:
G M, Bores, F P, Huger, W, Petko, A E, Mutlib, F, Camacho, D K, Rush, D E, Selk, V, Wolf, R W, Kosley, L, Davis, H M, Vargas
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(2)
Acetylcholinesterase (AChE) inhibitors from several chemical classes have been tested for the symptomatic treatment of Alzheimer's disease; however, the therapeutic success of these compounds has been limited. Recently, another AChE inhibitor, galant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::adbfcdf2868fbefad406fd3f2a33a8ca
https://pubmed.ncbi.nlm.nih.gov/8627552
https://pubmed.ncbi.nlm.nih.gov/8627552
Autor:
A T, Woods-Kettelberger, C P, Smith, R, Corbett, M R, Szewczak, J E, Roehr, G M, Bores, J T, Klein, S, Kongsamut
Publikováno v:
Brain research bulletin. 41(2)
The aim of the present paper is to report on the adrenergic and serotonergic effects of besipirdine (HP 749) in vivo and to discuss its potential use in the treatment of obsessive compulsive disorder. Besipirdine inhibited biogenic amine uptake in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81193a7417b28ad006b4c828959340bb
https://pubmed.ncbi.nlm.nih.gov/8879677
https://pubmed.ncbi.nlm.nih.gov/8879677